S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

NBY NovaBay Pharmaceuticals Inc New

0.6386

0.0086 (1.37%)

Last Updated: 14:10:12

Delayed by 15 minutes

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors

NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Jan 2025 to Feb 2025

Click Here for more NovaBay Pharmaceuticals Charts.

NovaBay Pharmaceuticals (AMEX:NBY)
Historical Stock Chart
From Feb 2024 to Feb 2025

Click Here for more NovaBay Pharmaceuticals Charts.

NovaBay Pharmaceuticals Inc New News

Form PRE 14A - Other preliminary proxy statements
Tuesday 18 February 2025 (6 days ago) • Edgar (US Regulatory)

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Thursday 6 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Tuesday 4 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 4 February 2025 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 23 January 2025 (1 month ago) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Thursday 23 January 2025 (1 month ago) • Edgar (US Regulatory)

NovaBay Pharmaceuticals Completes the Sale of its Eyecare Business to PRN and Further Adjourns its Special Meeting of Stockholders on Dissolution Proposal
Thursday 23 January 2025 (1 month ago) • Business Wire

Form 8-K - Current report
Wednesday 22 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 10 January 2025 (1 month ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 19 December 2024 (2 months ago) • Edgar (US Regulatory)

NovaBay Pharmaceuticals Announces the Further Adjournment of the Special Meeting of Stockholders
Thursday 19 December 2024 (2 months ago) • Business Wire

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Wednesday 11 December 2024 (2 months ago) • Edgar (US Regulatory)

More NovaBay Pharmaceuticals Inc New News Articles

Leonteq Securities

Exchange Traded Fund Ivz...

PancakeSwap Token

Vontobel Financial Produ...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions